Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency drugs in development, 2024

GlobalData tracks 6 drugs in development for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency by six companies/universities/institutes. The top development phase for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency is phase ii, with three drugs in that stage.

Aug 31, 2024 - 04:00

GlobalData tracks 6 drugs in development for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency by six companies/universities/institutes. The top development phase for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency is phase ii, with three drugs in that stage.

Read the original article

Tags:

Previous Article

Frontotemporal Dementia (FTD) drugs in development, 2024

Siemens Healthineers to Acquire Novartis’ European Radiodiagnostic Production Ne...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Alumis secures $259m to develop therapies for immune dysfunction

Alumis secures $259m to develop therapies for immune dy...

Mar 7, 2024

No nitrosamines: How parenteral packaging is evolving to meet today’s E&L challenges

No nitrosamines: How parenteral packaging is evolving t...

May 23, 2024

Eloxx repackages ELX-02 data in cystic fibrosis as it eyes pivotal trial

Eloxx repackages ELX-02 data in cystic fibrosis as it e...

Jun 15, 2023